Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of stock options outstanding and exercisable

v3.22.2.2
Stockholders' Equity (Details) - Schedule of stock options outstanding and exercisable
 6 Months Ended
Jun. 30, 2022
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Weighted Average Exercise Price
Stock Options, Total Outstanding (in Shares) | shares 9,776,252
Stock Options, Number Exercisable (in Shares) | shares 5,579,545
0.26 to 2.02 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum $ 0.26
Stock Options, Stock Options, Grant Price, Maximum 2.02
Stock Options, Weighted Average Exercise Price $ 1.17
Stock Options, Total Outstanding (in Shares) | shares 7,923,085
Stock Options, Number Exercisable (in Shares) | shares 3,830,440
Stock Options, Weighted Average Remaining Contractual Term 7 years 7 months 24 days
2.10 to 4.60 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum $ 2.1
Stock Options, Stock Options, Grant Price, Maximum 4.6
Stock Options, Weighted Average Exercise Price $ 2.74
Stock Options, Total Outstanding (in Shares) | shares 1,410,167
Stock Options, Number Exercisable (in Shares) | shares 1,306,105
Stock Options, Weighted Average Remaining Contractual Term 5 years 8 months 15 days
5.30 to 8.86 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Stock Options, Grant Price, Minimum $ 5.3
Stock Options, Stock Options, Grant Price, Maximum 8.86
Stock Options, Weighted Average Exercise Price $ 6.44
Stock Options, Total Outstanding (in Shares) | shares 443,000
Stock Options, Number Exercisable (in Shares) | shares 443,000
Stock Options, Weighted Average Remaining Contractual Term 5 years 10 months 6 days